In the setting of castrate-resistant prostate cancer, patients present with a variety of symptoms, including bone metastases, spinal cord compression and advanced pelvic disease. Fortunately, a variety of radiotherapeutic options exist for palliation. This article focuses on these options, including both external beam radiotherapy and radiopharmaceuticals.
No takes yet. Share an insight, caveat, or question.
Rose et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: